Mirae Asset Global Investments’s Emergent Biosolutions EBS Stock Holding History

Mirae Asset Global Investments’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-22,389	Closed	-$199K	–	1812
2024 Q1	$199K	Buy	+22,389	New	+$50.5K	﹤0.01%	2263
2023 Q4	–	Sell	-22,389	Closed	-$76.1K	–	2549
2023 Q3	$76.1K	Sell	22,389 -19,894	-47%	-$110K	﹤0.01%	2511
2023 Q2	$316K	Buy	42,283 +5,481	+15%	+$50.8K	﹤0.01%	2164
2023 Q1	$381K	Buy	36,802 +12,947	+54%	+$157K	﹤0.01%	2057
2022 Q4	$282K	Buy	23,855 +1,195	+5%	+$18.5K	﹤0.01%	2179
2022 Q3	$476K	Buy	22,660 +7,032	+45%	+$196K	﹤0.01%	1893
2022 Q2	$485K	Buy	+15,628	New	+$534K	﹤0.01%	1764

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Mirae Asset Global Investments's EBS Position: Q2 2024 in Review

Mirae Asset Global Investments sold out of Emergent Biosolutions (EBS) in Q2 2024, closing a stake of 22,389 shares — an estimated $199K sold.

Mirae Asset Global Investments first reported a position in EBS in Q2 2022 and held it in 7 quarters. The position peaked at $485K in Q2 2022. 141 funds tracked by Wall St. Rank hold EBS as of Q2 2024.

Mirae Asset Global Investments reported no remaining Emergent Biosolutions position as of Q2 2024 after selling out during the quarter.
Mirae Asset Global Investments sold 22,389 Emergent Biosolutions shares in Q2 2024, an estimated $199K.
Mirae Asset Global Investments first reported a position in Emergent Biosolutions in Q2 2022 and held it in 7 quarters.
Mirae Asset Global Investments's Emergent Biosolutions position peaked at $485K in Q2 2022.
141 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2024.

Based on Mirae Asset Global Investments's 13F filing for Q2 2024, filed 30 Jul 2024.